vendex and Tracheal-Neoplasms

vendex has been researched along with Tracheal-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for vendex and Tracheal-Neoplasms

ArticleYear
Usefulness of mini-tracheostomy and torque controlled insertion of applicator in fractionated endobronchial brachytherapy.
    The British journal of radiology, 2006, Volume: 79, Issue:942

    Endobronchial brachytherapy was developed as effective treatment of endobronchial cancer and fractionated schedule is applied to decrease late toxicity. However, repeated bronchofiberscopy is onerous to the patient and restricts the treatment schedule itself. We applied mini-tracheostomy for a ready access route, and a torque controlled technique for easy insertion of the endobronchial applicator. Eight patients with tracheobronchial cancer invasion were treated with endobronchial brachytherapy of 18-30 Gy/3-5 fractions/1.5-2.5 weeks (median 24 Gy/4 fractions/2 weeks) at reference points of 5 mm from the bronchial surface. The averaged individual irradiation and single session times were 4 min and 24 min, respectively. There were no procedure-related complications. These technical improvements may facilitate flexible fractionated dose prescriptions.

    Topics: Aged; Brachytherapy; Bronchial Neoplasms; Dose Fractionation, Radiation; Equipment Design; Female; Humans; Male; Middle Aged; Radiotherapy Dosage; Torque; Tracheal Neoplasms; Tracheostomy; Treatment Outcome

2006